Article Versions Notes

Elkazzaz M, Ahmed A, Abo-Amer YE-E, Hydara T, Haikal A, Razek DNAE, Eltayb WA, Wang X, Karpiński TM, Hamza D, et al. In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19. Vaccines. 2022; 10(9):1500. https://doi.org/10.3390/vaccines10091500

Elkazzaz, Mahmoud, Amr Ahmed, Yousry Esam-Eldin Abo-Amer, Tamer Hydara, Abdullah Haikal, Dina N. Abd El Razek, Wafa Ali Eltayb, Xiling Wang, Tomasz M. Karpiński, Dalia Hamza, and et al. 2022. "In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19" Vaccines 10, no. 9: 1500. https://doi.org/10.3390/vaccines10091500

Elkazzaz, M., Ahmed, A., Abo-Amer, Y. E.-E., Hydara, T., Haikal, A., Razek, D. N. A. E., Eltayb, W. A., Wang, X., Karpiński, T. M., Hamza, D., Jabbar, B., & Shamkh, I. M. (2022). In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19. Vaccines, 10(9), 1500. https://doi.org/10.3390/vaccines10091500